chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shingles; other zoster-related conditions; Information has been received from a lawyer and a patient of unknown age and gender regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. In 2014, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot#, expiration and route unknown) for the long-term prevention of shingles and zoster-related conditions. Subsequent to the inoculation (date not reported), the patient was treated by health care providers for shingles and other zoster-related conditions. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of the event shingles and other zoster-related conditions was not recovered. The causality assessment was considered as related by the lawyer.
Patient developed typical reaction to Covid-19 vaccine with fever, sore arm and headache within 17 hours of her 2nd Covid-19 vaccination. At the same time, she also developed left sided facial paralysis consistent with Bell's Palsy. Fever and headache had resolved at time of office visit. Treatment was initiated with prednisone 60  mg daily for 7 days.
Had a sore arm within hour of shot (got it at 7:30pm). Felt a little yucky before going to bed. I made sure to hydrate significantly before the shot and after. I woke up at 3am with chills and had them for about an hour.  Woke up the next morning at 9am with with medium neck and head pain and feeling a little chilly and out of it. Mild ache in joints and body overall. At 10am I took one ibuprofen, but at 11am (200mg), kept pushing fluids. 11am headache got worse temp 98.7 (slightly high for me, I am usually about 97). Started having some gastrointestinal issues around noon. Felt nausea and sweaty palms loss of appetite. Had a bowel movement (normal in appearance).    That all seemed to pass and I felt better, still tired, for most of the afternoon. Arm was sore to the touch and when moving. I managed to eat a few small meals, kept up hydration, and took a nap late in the day. I woke up at 5pm with headache and body aches all over. No appetite again. Had very little to eat, kept hydrating,    At 7pm my vision got a little blurry and I had a minor vasovagal episode. Center of vision blurred, got chills and sweaty, nausea, and I had to poop  (it was less formed). I rested, cool compress, and raised my feet. It all passed in about 20 minutes. I had major loss of appetite rest of the night (couldn't eat anything), kept hydrating, and went to bed.  Slept through the night with no incidents.   Woke up at 9am second day and had a small breakfast, though my appetite is still not back. Generally feeling exhausted, but no headache or aches in the body anymore. My arm is still sore. Had some more GI distress (another less formed poop around 11am).   My appetite returned by early afternoon on the 2nd day post-vaccine. Still tired and generally feeling "off," especially mentally. Had brain fog all afternoon and my ears felt plugged today. Hard to concentrate on a task.
fever; nausea; very sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 53-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733) via an unspecified route of administration in the right arm on 26Mar2021 at 10:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), Claritin and multi-vitamin (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 26Mar2021 at 15:00, the patient had experienced very sore arm which she could not lift her arm. On 28Mar2021, the patient experienced fever and nausea. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events very sore arm, fever and nausea was resolving at the time of this report.  No follow-up attempts are possible; No further information is expected.
Pt recv vax on 10/5/98; on 10/6/98 pt exp fever (102), red, warm & swollen left thigh; left thigh became bruised 3x3.5 in.
This case was reported by a physician via sales rep and described the occurrence of injection site pain in a adult male patient who received SHINGRIX. On 5th April 2018, the patient received the 1st dose of SHINGRIX .5 ml. On 5th April 2018, immediately after receiving SHINGRIX, the patient experienced injection site pain. On 6th April 2018, the patient experienced general body pain, fever and feeling bad. On an unknown date, the outcome of the injection site pain, general body pain, fever and feeling bad were unknown. It was unknown if the reporter considered the injection site pain, general body pain, fever and feeling bad to be related to SHINGRIX. Additional information was reported as follows: This case was reported by the physician who himself was the patient. The age at vaccination was not reported. The patient received SHINGRIX in the morning. The patient experienced pain immediately at the injection site, then 24 hours later experienced systemic pain, aches, suspected fever and felt lousy.
Severe vertigo, nausea and vomiting. Could not stand up for over 24 hours. Could not eat or drink water without vomiting for over 24 hours.  Symptoms subsided after 24 hours, but almost a week later I still wake up dizzy in the mornings. Dizziness subsides as I start moving around, but still do not feel fully normal.
Information has been received from a licensed practical nurse concerning an adult female who in August 2005, was vaccinated IM with 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 647661/0055R). In August 2005, the pt developed injection site reaction to include pain, local warmth, redness and swelling. The pt's were reported as recovered. There was no product quality complaint involved. Additional information has been requested.
Patient received 2nd dose of Pfizer on day 15 after his 1st dose (2 days before the 4 day grace period of the 21 day interval for Pfizer). He stated he felt he had some chest pain lasting approximately 3-4 days after 2nd dose. He said "the chest pain may have all been in my head though," therefore he did not seek treatment. Since the 2nd dose given on 02/12/2022 (too early, and invalid), the medical director recommended delaying the repeat dose until 8 weeks after the invalid dose; 04/09/2022.
Left. Eyelid swelling Left facial Lymph node pain and swelling from temple to check 13 day heavy menstruation. Multiple clots per hour of every single day
11:16 am Shortly after receiving vaccine, complained of pressure in chest, dizziness, body shaking, lightneaded.  Offered water and granola bar and ate the bar.  Blood sugar checked by EMT on site at 115 at 11:20 am.  BP=98/60, 99 O2 sat, 60 pulse and regular.  After about 10 minutes, recovered fully and was able to leave the clinic.  Roser is from Spain and limited English, so Spanish interpreter was used to communicate.
pt recv vax & over the next several days pt exp a h/a for 3-4 days;tx ASA; sx resolved;
Began having the sensation of being poked with needles all over my body.   Continuously.   Like a severe tingling.   Head to toe, including face and extremities.  ( With the 1st dose, I had the same sensations on a very slight level, and only on arms and legs and not all the time).    Sensations started day 2.  Severe at day 4, when I had to drive 4 hours to another State.  Accompanied by random dizziness, and feeling mentally "out of it" a little.  I'd read it was Ok to exercise after getting the shots, so Day 2 and 3 I attempted crossfit.   I got thru the classes, barely.    Afterward I thought I was going to pass out and I felt bizarre, mostly my head.    Very unwell.   I would also get random hot flashes with dizziness.   I am perimenopause, but dont have hot flashes very much any longer and they dont make me dizzy.    With the day 4 severity of the needles sensation,  I honestly started to worry.   I decided Id see a doctor upon my return to home, which would be day 7.    Today is day 7 after dose 2.   Huge improvement, but still having some of the sensations,  so I dont plan to reach out to my doctor unless my next workout feels like the ones last week.   I expected the common side effect of tiredness and fever chills, but got this crazy stuff that felt like my nervous system was misfiring/freaking out.   I am afraid to get a booster shot for Covid if that's the path in a few months!
Breakthrough case. On 5/1/2022 I got an ear ache in my right ear. Then that night it travelled to left ear as well, I started feeling a post nasal drip and my throat was irritated. Next day the pain in ears and throat were worse had sinus congestion and nasal discharge increased and was coughing. Felt really fatigued and had body aches with shivering intermittently throughout. No fever. Took home COVID-19 test and it was positive. Called Dr and was prescribed Paxlovid. After 1st dose, symptoms started lessening within hours. Tested again and was negative on 05/10/2022.
VERY LOW TEMPERATURE; VERY LIGHT-HEADED; LIPS WERE COLD; MUSCLE SORENESS; CHILLS; HEADACHE; BODY ACHES /LITTLE SORE; FEELING WORSE; This spontaneous report received from a patient concerned a 62 year old female. The patient's weight was 170 pounds, and height was not reported. The patient's concurrent conditions included depression. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A expiry: UNKNOWN) dose was not reported, administered on 06-MAY-2021 13:00 for prophylactic vaccination. Concomitant medications included bupropion hydrochloride for depression.  On MAY-2021, the subject experienced body aches /little sore. On MAY-2021, the subject experienced feeling worse. On 06-MAY-2021, the subject experienced headache. On 07-MAY-2021, the subject experienced chills. On 07-MAY-2021, the subject experienced muscle soreness. On 08-MAY-2021, the subject experienced very low temperature. On 08-MAY-2021, the subject experienced very light-headed. On 08-MAY-2021, the subject experienced lips were cold. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 94 F. Treatment medications (dates unspecified) included: naproxen sodium, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, chills, muscle soreness, body aches /little sore, lips were cold, very low temperature, very light-headed and feeling worse was not reported. This report was non-serious.
Information has been received from a consumer concerning her son who on 06/04/2001 was vaccinated with varicella vaccine. It was reported that the pt expereinced dizziness since vaccination on 06/04/2001. It was also noted that on 06/05/2001 the pt complained of a stomachache. Unspecified medical attention was sought. The pt's mother would not provide any additional details. No further info is available.
This spontaneous report as received from a pharmacist technician refers to a multiple anonymous patients of unknown age. On an unknown date the patients were vaccinated with VAQTA (dose and route of administration were not provided). On an unknown date the patients have been administered VAQTA post supported excursion. No adverse effects noted by any patients. This is one of several reports from the same source. Additional information has been requested.
patient had a reaction in 2016 to the flu shot, required hospitalization; Initial information received on 15-Dec-2020 regarding an unsolicited valid serious case received from a consumer (patient). This case involves a patient with an unknown age and gender who had a reaction in 2016 (adverse reaction), while he/she received INFLUENZA VACCINE.  The patient's medical history, medical treatments, vaccinations and family history were not provided.  The patient taken vitamins and supplements.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) (batch number and expiry date not reported) via an unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date in 2016, the patient had a reaction (adverse reaction) unknown latency following the administration of INFLUENZA VACCINE. The patient was hospitalized for this event.  No relevant laboratory tests were reported.  It was not reported if the patient received a corrective treatment.  Event outcome was unknown, at the time of reporting.  Information regarding the batch number was requested for the case.; Sender's Comments: This case involves patient with an unknown age who had reported adverse reaction after vaccination with INFLUENZA VACCINE (produced by unknown manufacturer). The time to onset is unknown. Further information regarding previous vaccination, tolerance and laboratory tests ruling out alternate etiologies were needed to fully assess this case. Based upon the reported information, the role of the suspect vaccine cannot be assessed.
Severe fatigue, paresthesias, and pre-syncope if tries to leave a supine position.
Severe diarrhea; This is a spontaneous report from a non-contactable consumer (patient herself). A 46-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number unknown), via an unspecified route of administration on unspecified date at SINGLE DOSE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient did not have COVID-19 prior vaccination. The patient did not test for COVID-19 post vaccination. It was reported that the patient did not receive other vaccines in four weeks, "other vaccine same date details" were also provided as 24Jan2021 (as reported). The patient experienced severe diarrhea on 24Jan2021 12:30 which resulted in Emergency room/department or urgent care. Therapeutic measures were taken as a result of severe diarrhea. Outcome of the event was not recovered.  No follow-up attempts are possible; Information on the lot/batch number cannot be obtained.
Two days after immunization patient complained of itching and burning of right deltoid area. Had induration of 20mm (2.5cm) with red rash.
sore; hot; itching; rash; big red welt on her arm; red; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE WARMTH (hot), INJECTION SITE PRURITUS (itching), RASH (rash), INJECTION SITE URTICARIA (big red welt on her arm) and INJECTION SITE ERYTHEMA (red) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sulfonamide allergy (Allergy to sulfa).    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced INJECTION SITE WARMTH (hot), INJECTION SITE PRURITUS (itching), RASH (rash), INJECTION SITE URTICARIA (big red welt on her arm) and INJECTION SITE ERYTHEMA (red). On 20-Jan-2021, the patient experienced INJECTION SITE PAIN (sore). At the time of the report, INJECTION SITE WARMTH (hot), INJECTION SITE PRURITUS (itching), RASH (rash), INJECTION SITE URTICARIA (big red welt on her arm), INJECTION SITE ERYTHEMA (red) and INJECTION SITE PAIN (sore) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.    Most recent FOLLOW-UP information incorporated above includes: On 21-Jan-2021: Follow-up information included additional details regarding the patient, and the reported events. On 25-Jan-2021: Follow-up information included additional patient information.
Patient states on 2/23/2021 at about 0130 am , he began feeling " restless , body aches, and headache".  Patient took some Excedrin at that time for headache.  Sudden onset of pain to left kidney area as per patient , with chills and continued body aches. Denies urinary symptoms or hematuria.   Onset of fever at about 5 am which was 99.7 temporal , at 1130 am patient stated his temperature was " 107.2 temporal" . Patient asked about high fever and states he was alert and oriented and repeated temperature at about 12pm and was 103 F. orally.  Took 800mg of Motrin , called his PCM who instructed patient to go to Emergency Department.  Stated his pulse on arrival to ER was 117 beats /minute , blood pressure was 101/55.   States had a provider evaluation and was discharged from ER.
Rashes with small fluid-filled blisters began appearing about 1 week after the shot. Rashes were found sometimes on the arms, but mostly in the lower leg, ankle, and foot area, where spider veins were present. When the rashes first appeared, one of the spider veins at the ankle appeared to have recently burst. Within one month of the shot, I noticed that at rest, my head was moving side to side subtly with my heartbeat. This appears to worsen with caffeine consumption. Around July 11, I began to experience daily dizziness. When blood pressure was measured on the left arm with an at-home device, systolic measurements were as low as 81 and averaged 88.9. Diastolic measurements were as low as 60 and averaged 66.6. Symptoms are now being managed using herbal remedies and are showing improvement. Whether this improvement is temporary or long-lasting is yet to be determined.
Information has been received from a registered nurse regarding to a dialysis patients (specific number of patient were unknown). On an unknown date, the patients were vaccinated with the completed doses of RECOMBIVAX HB vial 40mcg/mL (route and lot number was not provided). No other co-suspects were reported. No concomitant medications were reported. On an unknown date, the patients who completed RECOMBIVAX HB dialysis formulation were tested for antibody level and result came back less than 10 mIU/mL. It was unknown if the patients received treatment for the adverse event or sought medical attention. The patients outcome were unknown at the time of the report. The relatedness between RECOMBIVAX HB and the event was not reported. Additional information is not expected.
Temperature spike to 101F, significant chills and shaking for 60 minutes, headache, generalized body aches, nausea, very sore left arm
3 hours after receiving PNEUMOVAX, patient noted her left arm (site of injection) was "knotty" and sore and she could not lay on it. The next morning the knot has gone but soreness remained. Patient denied redness, fainting, trouble breathing or any other issues. Patient denied any reaction to a previous shot including PREVNAR 1 year ago.
Systemic: Allergic: Itch Generalized-Mild, Systemic: Allergic: Rash Generalized-Mild, Additional Details: Patient experienced skin itchiness and a rash on his back. Was given a dose of benadryl. The rash of the patient's back started clearing out after a couple of minutes.
pneumonia; Initial information received on 16-Oct-2020 regarding an unsolicited valid serious case from a consumer/non-health care professional  via social media .  This case involves patient of unknown demographics who had pneumonia, after receiving INFLUENZA VACCINE and PNEUMOCOCCAL VACCINE.  The patient's past vaccinations included flu shot every year and have had pneumonia.  Family history was not provided.  At the time of the event, the patient had ongoing COPD (Chronic obstructive pulmonary disease).  Concomitant medications included oxygen or concentrator.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer ,lot number and expiration date not reported) and  a dose of suspect PNEUMOCOCCAL VACCINE (not produced by Sanofi Pasteur ,lot number and expiration date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date , the patient developed a serious pneumonia shortly after (exact latency unknown) following the administration of INFLUENZA VACCINE and PNEUMOCOCCAL VACCINE. This event was assessed as medically significant.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was unknown for the event pneumonia.  Information on the batch number was requested.; Sender's Comments: This case involves patient who had pneumonia, shortly after the vaccination with INFLUENZA VACCINE and PNEUMOCOCCAL VACCINE. The time to onset is compatible. The patient has ongoing condition of COPD (Chronic obstructive pulmonary disease) and the lab tests were not reported. Based upon the reported information, the role of the vaccine cannot be assessed separately from the pre-existing pathology.
48 hours after vaccine, at 3 pm, I developed an allergic response. I had diarrhea, hives, itchy eyes, mouth, and throat, coughing, and slight constriction in my lungs. Within 30 minutes of taking Benadryl the symptoms began to subside. After the allergic reaction, I developed the normal symptoms of the vaccine with chills, fever, body aches and a headache. Injection site had increased soreness for the rest of the day.
PT HAS REDNESS AT SITE OF INJECTION (APPROXIMATELY 3 INCH DIAMETER) AND BUMP
tingling sensation of upper lip at 13:40. Injection given at 13:27.  Tingling and  numbness of lips
just tired from the pfizer in March. I was diagnosed with covid on 09/16/2021, massive headache, sinus congestion, severe cough, body aches, fever now thrush.